Peter Small, has led the call for more patient-centered ways of assisting TB patients with treatment adherence. In this video, published by the Rockefeller Foundation, Peter shares how emerging technologies can make it easier for patients.
Earlier this year, Arcady Founder, Bruce Thomas presented at the HealthXL Global Gathering in Melbourne, Australia. HealthXL Global Gatherings showcase innovation on a global platform by bringing together people with ideas, resources and desire to contribute to the evolution of healthcare. This year’s event assembled leaders and innovators of the world’s most disruptive health technology […]
Over the past several years, a number of studies have been published demonstrating the feasibility, acceptability, and adherence enhancing impact of medication adherence monitoring technologies on TB medication adherence in high-burden regions. However, none of these studies have evaluated health outcomes as a primary endpoint. Bruce Thomas, Arcady Founder, is a contributing author for recently […]
The Arcady Group, LLC, a consulting company that works to enhance patient and disease management by addressing the challenges of medication non-adherence, has been awarded a grant from the Bill & Melinda Gates Foundation to continue Arcady’s activities to improve TB medication adherence and TB treatment outcomes. Under this most recent grant, the third from […]
Since the launch in the Fall, 2017, we have been assisting the Stop TB Partnership in its TB REACH Wave 6 Call for Proposals. The TB REACH initiative receives funding from the Global Affairs Canada, the Bill and Melinda Gates Foundation, the Indonesia Health Fund, and the United States Agency for International Development to fund and […]
In 2017, the WHO took the critical steps of acknowledging the need for/impact of adherence interventions and approving certain evidence-based adherence technologies for use with DS-TB patients. In 2018, the Stop TB Partnership, through its TB REACH initiative, has selected and will soon be funding 14 projects demonstrating the feasibility, acceptability, and health outcomes […]
Just 4 short years ago, Microsoft researchers in India were ideating around a way to monitor patient adherence to TB medications without requiring clinic visits (DOT), which create challenges for patients and an enormous burden for providers. Building on the idea of sending free messages via “missed calls,” an early 99DOTS prototype was born with handwritten […]